BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corcoran JP, Hallifax R, Rahman NM. New therapeutic approaches to pleural infection. Curr Opin Infect Dis 2013;26:196-202. [PMID: 23286936 DOI: 10.1097/QCO.0b013e32835d0b71] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Idell S, Florova G, Shetty S, Tucker T, Idell R, Koenig K, Azghani A, Rahman NM, Komissarov A. Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential. Clin Pulm Med 2017;24:163-9. [PMID: 29081644 DOI: 10.1097/CPM.0000000000000216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
2 Tucker TA, Idell S. The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review. Int J Mol Sci 2021;22:1437. [PMID: 33535429 DOI: 10.3390/ijms22031437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Komissarov AA, Rahman N, Lee YCG, Florova G, Shetty S, Idell R, Ikebe M, Das K, Tucker TA, Idell S. Fibrin turnover and pleural organization: bench to bedside. Am J Physiol Lung Cell Mol Physiol 2018;314:L757-68. [PMID: 29345198 DOI: 10.1152/ajplung.00501.2017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
4 Florova G, Azghani A, Karandashova S, Schaefer C, Koenig K, Stewart-Evans K, Declerck PJ, Idell S, Komissarov AA. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol 2015;52:429-37. [PMID: 25140386 DOI: 10.1165/rcmb.2014-0168OC] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
5 Idell S, Rahman NM. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns. Ann Am Thorac Soc 2018;15:515-7. [PMID: 29361235 DOI: 10.1513/AnnalsATS.201711-848PS] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
6 Komissarov AA, Florova G, Azghani A, Karandashova S, Kurdowska AK, Idell S. Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids. Am J Physiol Lung Cell Mol Physiol 2013;305:L682-92. [PMID: 23997178 DOI: 10.1152/ajplung.00102.2013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
7 Kwon YS. Pleural infection and empyema. Tuberc Respir Dis (Seoul). 2014;76:160-162. [PMID: 24851128 DOI: 10.4046/trd.2014.76.4.160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
8 Varsamas C, Kalkanis A, Gourgoulianis KI, Malli F. The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions. Can Respir J 2020;2020:1283590. [PMID: 33082889 DOI: 10.1155/2020/1283590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Gilbert CR, Gorden JA. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens. Curr Opin Pulm Med 2017;23:371-5. [PMID: 28399008 DOI: 10.1097/MCP.0000000000000387] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Tucker TA, Jeffers A, Alvarez A, Owens S, Koenig K, Quaid B, Komissarov AA, Florova G, Kothari H, Pendurthi U, Mohan Rao LV, Idell S. Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury. Am J Respir Cell Mol Biol 2014;50:316-27. [PMID: 24024554 DOI: 10.1165/rcmb.2013-0300OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 0.5] [Reference Citation Analysis]
11 Florova G, Azghani AO, Karandashova S, Schaefer C, Yarovoi SV, Declerck PJ, Cines DB, Idell S, Komissarov AA. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2018;314:L54-68. [PMID: 28860148 DOI: 10.1152/ajplung.00579.2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Tomlinson JE, Byrne E, Pusterla N, Magdesian KG, Hilton HG, McGorum B, Davis E, Schoster A, Arroyo L, Dunkel B, Carslake H, Boston RC, Johnson AL. The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012). J Vet Intern Med 2015;29:1403-9. [PMID: 26256909 DOI: 10.1111/jvim.13594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
13 Yang W, Zhang B, Zhang ZM. Infectious pleural effusion status and treatment progress. J Thorac Dis 2017;9:4690-9. [PMID: 29268539 DOI: 10.21037/jtd.2017.10.96] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Beckert L, Brockway B, Simpson G, Southcott AM, Lee YCG, Rahman N, Light RW, Shoemaker S, Gillies J, Komissarov AA, Florova G, Ochran T, Bradley W, Ndetan H, Singh KP, Sarva K, Idell S. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema. JCI Insight 2019;5:127470. [PMID: 30998508 DOI: 10.1172/jci.insight.127470] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
15 Ferreiro L, Lado-Baleato Ó, Suárez-Antelo J, Toubes ME, San José ME, Lama A, Rodríguez-Núñez N, Álvarez-Dobaño JM, González-Barcala FJ, Ricoy J, Gude F, Valdés L. Diagnosis of infectious pleural effusion using predictive models based on pleural fluid biomarkers. Ann Thorac Med 2019;14:254-63. [PMID: 31620209 DOI: 10.4103/atm.ATM_77_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]